<

NEW TO THE STREET (NASDAQ:MODD) Modular Medical Announces Participation at Upcoming Investor Conferences

Transparency directive : regulatory news

23/11/2022 17:20

SAN DIEGO, CA / ACCESSWIRE / November 23, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, will be participating in the following investor conferences:

Piper Sandler 34th Annual Healthcare Conference at the Lotte New York Palace Hotel in New York City: Mr. Besser will make a corporate presentation on November 30, 2022, beginning at 10:50 a.m. ET. In addition, Mr. Besser will host one-on-one meetings on November 30, 2022. To schedule a one-on-one meeting, please contact your Piper Sandler representative.

Benchmark Company's 11th Annual Discovery Investor Conference at the New York Athletic Club in New York City: Mr. Besser will host one-on-one meetings with investors on December 1, 2022. To schedule a one-on-one meeting, attendees should submit a request online via the link provided upon registration. To attend the conference, please register at: https://www.benchmarkcompany.com/news-events/upcoming-events/the-11th-annual-discovery-one-on-one-investor-conference

About Modular Medical, Inc.

Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

All trademarks mentioned herein are the property of their respective owners.

CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.



View source version on accesswire.com:
https://www.accesswire.com/728127/Modular-Medical-Announces-Participation-at-Upcoming-Investor-Conferences

source : webdisclosure.com



Other stories

07/12/2024 05:25
06/12/2024 23:10
06/12/2024 19:09
05/12/2024 17:39
07/12/2024 02:30
06/12/2024 13:33
06/12/2024 18:44
06/12/2024 18:20
06/12/2024 15:36
06/12/2024 18:37
06/12/2024 15:23
06/12/2024 18:46
06/12/2024 20:49
05/12/2024 19:29
06/12/2024 18:55
06/12/2024 22:19
06/12/2024 20:42
06/12/2024 17:38
06/12/2024 09:05
06/12/2024 08:01
06/12/2024 17:56
06/12/2024 23:45
07/12/2024 00:11
07/12/2024 01:50
07/12/2024 00:20
07/12/2024 03:27
07/12/2024 03:31
06/12/2024 19:31
06/12/2024 23:31
06/12/2024 23:46
06/12/2024 05:39
06/12/2024 00:02
06/12/2024 14:03
06/12/2024 15:54
07/12/2024 03:52
06/12/2024 09:56
05/12/2024 14:17
06/12/2024 05:00